A medida que Novo Nordisk remonta terreno a su rival Lilly, la batalla contra la obesidad se intensifica
Global - South America
Archived
•
August 3, 2026
•
2 views
La farmacéutica danesa se está beneficiando de su píldora para adelgazar Wegovy, que mantiene el liderazgo frente a Foundayo de Lilly
Source: El País América | https://feeds.elpais.com/mrss-s/pages/ep/site/elpais.com/section/america/portada - Read Original
"What you put in is not always what you get out."
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"Get your business promoted today."
